Consumer preference surveys or sales data

FDA Authorizes First Nicotine Pouch, ZYN, to Help Adult Smokers Quit

Jan 16, 2025, 07:45 PM

The U.S. Food and Drug Administration (FDA) has authorized the marketing of 20 ZYN nicotine pouch products following an extensive scientific review, marking the first time the agency has approved such products. The authorization comes with stringent marketing restrictions to prevent youth use, and the FDA will closely monitor compliance. The products, which include 10 flavors like coffee, mint, and menthol, are intended for adults aged 21 and older. The FDA's decision is based on evidence showing that ZYN poses a lower risk of cancer and other serious health conditions compared to cigarettes and most smokeless tobacco products. Philip Morris International's ZYN is aimed at helping adult smokers cut back or quit cigarettes, with the FDA noting that a substantial portion of adult smokers have completely switched to these nicotine pouches. However, the FDA clarifies that these products are not considered safe.